WANBURY240.65

Wanbury Limited

· Pharma & Health
₹ CrorePeersAHCLANUHPHRBAJAJHCARETHEMISMEDZIMLABLINCOLNSIGACHIVALIANTLABMcap ₹789 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
Last 12M
30/06/2025
Non-current Assets
+ Property, Plant & Equipment151.5149.0189.7189.7
+ Capital Work-in-Progress1.63.05.45.4
+ Goodwill0.017.510.710.7
+ Other Intangibles0.10.30.20.2
+ Non-current Investments0.00.00.00.0
+ Other Non-current Financial Assets4.26.94.04.0
Non-current Financial Assets4.26.94.14.1
+ Deferred Tax Assets5.55.57.07.0
+ Other Non-current Assets16.81.93.43.4
Total Non-current Assets179.7184.2220.5220.5
Current Assets
+ Inventories22.036.037.737.7
+ Current Investments0.00.00.10.1
+ Trade Receivables68.089.4114.2114.2
+ Cash & Cash Equivalents1.53.44.14.1
+ Other Bank Balances2.42.58.88.8
+ Other Current Financial Assets0.90.92.12.1
Current Financial Assets72.896.3129.2129.2
+ Other Current Assets27.427.026.526.5
Total Current Assets122.2159.3193.4193.4
Total Assets303.9343.5413.9413.9
Equity
+ Equity Share Capital32.732.732.832.8
+ Other Equity / Reserves-65.5-4.826.526.5
Equity — Owners of Parent-32.827.959.359.3
Total Equity-32.827.959.359.3
Liabilities
+ Borrowings — Non-current0.082.0160.3160.3
+ Other Non-current Financial Liab3.91.51.5
Non-current Financial Liabilities0.085.9161.8161.8
+ Provisions — Non-current13.915.517.517.5
+ Other Non-current Liabilities2.40.80.8
Non-current Liabilities16.3101.4180.0180.0
+ Borrowings — Current64.128.012.912.9
+ Trade Payables148.5162.7138.5138.5
+ Other Current Financial Liab80.58.46.16.1
Current Financial Liabilities293.1199.1157.5157.5
+ Provisions — Current2.73.02.62.6
+ Current Tax Liabilities1.50.00.0
+ Other Current Liabilities23.112.014.614.6
Current Liabilities320.4214.1174.6174.6
Total Liabilities336.7315.6354.6354.6
Total Equity & Liabilities303.9343.5413.9413.9
Assets — additional as-filed lines
+ Non-current Assets Held for Sale2.00.00.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current4.04.0
+ Dues to Other Creditors — Current134.5134.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.